Motif Bio plc Warrants to Purchase ADRs
MTFBW
MTFBW was delisted on the 16th of December, 2019.
4 hedge funds and large institutions have $147K invested in Motif Bio plc Warrants to Purchase ADRs in 2019 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and closing their positions.
33% more funds holding
Funds holding: 3 → 4 (+1)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
84% less capital invested
Capital invested by funds: $934K → $147K (-$787K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$35.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$1.61K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Invesco
Atlanta,
Georgia
| $115K | – | – | – |
|
|
SGCM
2
Sand Grove Capital Management
London,
United Kingdom
| $27K | – | – | – |
|
|
WAM
3
Wolverine Asset Management
Chicago,
Illinois
| $5K | +$35.7K | +21,196 | New |
|
|
4
UBS Group
Zurich,
Switzerland
| – | -$1.61K | -958 | -88% |
|
MTFBW Hedge Fund Activity: Q1 2019 in Review
4 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in Motif Bio plc Warrants to Purchase ADRs (MTFBW) for Q1 2019, worth a combined $147K — down 84% from $934K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new MTFBW positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Wolverine Asset Management, opening a new position worth an estimated $35.7K. The largest seller was UBS Group, cutting an estimated $1.61K.
- 4 institutional investors held Motif Bio plc Warrants to Purchase ADRs (MTFBW) as of Q1 2019, up from 3 in Q4 2018.
- Funds reported $147K of Motif Bio plc Warrants to Purchase ADRs stock for Q1 2019, down 84% quarter-over-quarter.
- 1 fund opened new Motif Bio plc Warrants to Purchase ADRs positions in Q1 2019 and 0 closed out, a net change of +1 holder.
- The largest Motif Bio plc Warrants to Purchase ADRs buyer in Q1 2019 was Wolverine Asset Management, an estimated $35.7K added.
- The largest Motif Bio plc Warrants to Purchase ADRs seller in Q1 2019 was UBS Group, an estimated $1.61K sold.
Based on aggregated 13F filings for Q1 2019.